EXELON CORP
Other · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $24.26B | $23.03B | $21.73B | $19.08B | $17.94B | $16.66B |
| Operating income | $5.15B | $4.32B | $4.02B | $3.31B | $2.68B | $2.19B |
| Net income | $2.77B | $2.46B | $2.33B | $2.17B | $1.83B | $1.95B |
| Total assets | $116.57B | $107.78B | $101.86B | $95.35B | $133.01B | $129.32B |
| Total liabilities | $87.77B | $80.86B | $76.10B | $70.61B | $98.22B | $94.45B |
| Equity | $28.80B | $26.92B | $25.75B | $24.74B | $34.39B | $32.59B |
| EPS (diluted) | — | — | — | — | $1.74 | $2.01 |
| Shares out. | 1.01B | 999.5M | 994.1M | 980.1M | 976.3M | 974.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 21.2%
- Net margin
- 11.4%
- Return on equity
- 9.6%
- Return on assets
- 2.4%
- Return on capital (ROCE)
- 4.8%
- Liabilities / assets
- 75.3%
- Debt / equity
- 3.05×
- Book value / share
- $28.65
- Revenue growth (YoY)
- 5.3%
- Net income growth (YoY)
- 12.5%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 0.81distress
- Accruals / assets
- −3.0%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 warning● 4 good- Altman Z″ in the distress zone
- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Blackrock, Inc.Passive (13G)Apr 23, 2025
- Wellington Management Group LlpPassive (13G)Feb 10, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Segedi Bryan KDirector | Mar 31, 2026 | Grant | 878 | $49.82 |
| Rogers Matthew CDirector | Mar 31, 2026 | Grant | 878 | $49.82 |
| Richo AnnaDirector | Mar 31, 2026 | Grant | 878 | $49.82 |
| Lillie Charisse RDirector | Mar 31, 2026 | Grant | 878 | $49.82 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Results of operations · Regulation FD disclosureMay 6, 2026
- Shareholder voteApr 30, 2026
- Regulation FD disclosure · Other material eventApr 16, 2026
- Entered a material agreement · New financial obligationFeb 20, 2026
- Results of operations · Regulation FD disclosureFeb 12, 2026
- Entered a material agreement · New financial obligation · Unregistered equity sale · Other material eventDec 4, 2025
- Director / officer changeNov 26, 2025
- Regulation FD disclosureNov 24, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Corporate family
Spin-offs from EXELON CORP (1)
- Constellation Energy CorpCEGcompletedJan 31, 2022details
From the spin-off filings we track. Follow a company to walk its own history.